Table 2.
Binary logistic regression analysis for 6-month mortality in lung cancer patients with an OE
| 6-months mortality | |||
|---|---|---|---|
| Variables | N | OR (95% CI) | P * |
| Age | |||
| <66 | 39 | Referent | |
| ≥66 | 43 | 0.72 (0.2–2.4) | 0.600 |
| Gender | |||
| Male | 60 | Referent | |
| Female | 22 | 1.53 (0.2–10.4) | 0.659 |
| Histology | |||
| NSCLC | 68 | Referent | |
| SCLC | 11 | 0.28 (0.0–1.9) | 0.190 |
| Others | 3 | - | - |
| Smoking | |||
| Non smoker | 16 | Referent | |
| Smoker/ex | 66 | 0.62 (0.1–5.8) | 0.680 |
| Stage at LC diagnosis | |||
| Non metastatic | 12 | Referent | |
| Metastatic | 70 | 0.35 (0.1–2.1) | 0.258 |
| Treatment at OE | |||
| No | 45 | Referent | |
| Yes | 37 | 0.41 (0.1–1.5) | 0.172 |
| Type of OE | |||
| Cardiovascular | 26 | Referent | |
| Neurologic | 43 | 0.25 (0.1–0.9) | 0.035 |
| Respiratory | 13 | 0.49 (0.0–2.8) | 0.421 |
| Year | |||
| 2019 | 36 | Referent | |
| 2020 | 46 | 2.07 (0.6–6.7) | 0.228 |
Abbreviations: OE, oncologic emergency; OR, odd-ratio; NSCLC, non-small cell lung cancer; SCLC, small cell lung cancer
*Multivariate logistic regression